EDAP
Edap Tms S.a.
NASDAQ · Healthcare · Medical - Devices · FR
$4.76
−0.52%Year over year
Reported trailing growth
- Revenue
- +14.7%
- EBITDA
- -15.3%
- EBIT
- -14.8%
- EPS
- -32.3%
- Free cash flow
- +0.8%
- Operating cash flow
- +14.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +8.7%
- EBITDA
- -57.3%
- EBIT
- -22.8%
- Net income
- -54.3%
- EPS
- -52.9%
- Free cash flow
- -25.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026